064550 — Bioneer Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Bioneer, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	206,987	223,744	218,394	263,237	293,975
Cost of Revenue
Gross Profit	162,586	174,197	166,648	203,008	219,925
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	103,678	176,635	206,812	262,410	307,541
Operating Profit	103,310	47,109	11,582	827	-13,566
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	55,650	43,278	13,904	-67	-15,325
Provision for Income Taxes
Net Income After Taxes	59,188	29,199	15,122	-6,919	-19,042
Minority Interest
Net Income Before Extraordinary Items
Net Income	57,899	27,160	12,077	-10,587	-20,584
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	59,111	27,160	12,077	-10,587	-20,584
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2,456	1,050	466	-411	-795
Dividends per Share